CD44 and breast carcinoma: Immunohistochemical analysis of the tumor tissue sections with antibodies (Table ST3) revealed a significant increase in the colocalization of GFP and CD44 in the CD24−/CD44+‐breast CSC as compared with the CD24+‐breast cancer cell xenotransplanted groups (Figure 5A).